Control group n = 46 | GDT group n = 44 | P value | |
---|---|---|---|
Age (years) | 66 ± 12 | 68 ± 9 | 0.28 |
Sex (male) | 29 (63%) | 26 (59%) | 0.83 |
Height (cm) | 160.2 ± 8.7 | 159.3 ± 9.6 | 0.65 |
Weight (kg) | 59.1 ± 10.2 | 54.0 ± 10.5 | 0.022 |
BMI (kg/m2) | 23.0 ± 3.4 | 21.2 ± 2.9 | 0.007 |
Patients receiving preoperative chemotherapy | 16 (35%) | 21 (48%) | 0.28 |
Preoperative renal function | |||
Serum creatinine (μmol/L) | 61 ± 18 | 56 ± 17 | 0.13 |
eGFR (mL/min/1.73m2)* | 85 ± 25 | 92 ± 25 | 0.20 |
ASA PS | |||
1 | 13 (28%) | 7 (16%) | 0.26 |
2 | 27 (59%) | 27 (61%) | |
3 | 6 (14%) | 10 (23%) | |
4 | 0 | 0 | |
Anesthetic agent | |||
Propofol | 29 (63%) | 23 (52%) | 0.39 |
Inhalational | 17 (37%) | 21 (48%) | |
Duration of surgery (min) | 432 ± 78 | 434 ± 80 | 0.92 |
Estimated blood loss (mL/kg) | 9.8 ± 7.5 | 9.3 ± 5.0 | 0.71 |